PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 28.95 CHF 2.3%
Market Cap: 959.1m CHF

Operating Margin

-2.5%
Current
Improving
by 2.3%
vs 3-y average of -4.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-2.5%
=
Operating Income
€-8.5m
/
Revenue
€370.5m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-2.5%
=
Operating Income
CHf-8.5m
/
Revenue
€370.5m

Peer Comparison

Country Company Market Cap Operating
Margin
CH
PolyPeptide Group AG
SIX:PPGN
933.7m CHF
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.2T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
233.6B USD
Loading...
US
Danaher Corp
NYSE:DHR
166.7B USD
Loading...
CH
Lonza Group AG
SIX:LONN
37.7B CHF
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
291.5B CNY
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.5B USD
Loading...
US
Agilent Technologies Inc
NYSE:A
39.6B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.8B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.2B EUR
Loading...
No Stocks Found

Market Distribution

Lower than 86% of companies in Switzerland
Percentile
14th
Based on 1 083 companies
14th percentile
-2.5%
Low
-62 472.2% — 3.5%
Typical Range
3.5% — 16.5%
High
16.5% — 91.2%
Distribution Statistics
Switzerland
Min -62 472.2%
30th Percentile 3.5%
Median 10.3%
70th Percentile 16.5%
Max 91.2%

PolyPeptide Group AG
Glance View

PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.

PPGN Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-2.5%
=
Operating Income
€-8.5m
/
Revenue
€370.5m
What is PolyPeptide Group AG's current Operating Margin?

The current Operating Margin for PolyPeptide Group AG is -2.5%, which is above its 3-year median of -4.7%.

How has Operating Margin changed over time?

Over the last 3 years, PolyPeptide Group AG’s Operating Margin has decreased from 17.2% to -2.5%. During this period, it reached a low of -12.8% on Jun 30, 2023 and a high of 17.2% on Jun 30, 2022.

Back to Top